Signals, Powered By EquityPandit
Lupin has announced the launch of pain relief drug Hydrocodone Bitartrate and Acetaminophen in the US market.
Lupin has said in a BSE filing that it has “launched Hydrocodone Bitartrate and Acetaminophen tablets USP, in the strengths of 5 mg/300 mg, 7.5 mg/300mg and 10 mg/300 mg having received an approval from the United States Food and Drug Administration (USFDA) earlier.”
Lupin has said in November last year that it had received final approval from the US health regulator for its Hydrocodone Bitartrate and Acetaminophen tablets that are used to provide pain relief.
